Alnylam Pharmaceuticals (1ALNY.MI) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.79
0
0.8
1.59

Details

Expected EPS
0.9739004113999999
Actual EPS
0.6908827999999999
Surprise EPS
-0.28
Surprise Percent
+29.06%

Description

Alnylam Pharmaceuticals (1ALNY.MI) has reported earnings of 0.6908827999999999 per share for Q1 2026.

0 Comments

Share your thoughts